Uswisi - Kijerumani - Swissmedic (Swiss Agency for Therapeutic Products)

glaxosmithkline ag - haemagglutininum influenzae a (h1n1) (virus stamm a/victoria/2570/2019 (h1n1)-like: reassortant virus ivr-215 derived from a/victoria/2570/2019), haemagglutininum influenzae a (h3n2) (virus stamm a/cambodia/e0826360/2020 (h3n2)-like: reassortant virus ivr-221 derived from a/tasmania/503/2020), haemagglutininum influenzae b (virus stamm b/washington/02/2019-like: reassortant virus b/washington/02/2019 (victoria lineage)) - injektionssuspension - haemagglutininum influenzae a (h1n1) (virus stamm a/victoria/2570/2019 (h1n1)-like: reassortant virus ivr-215 derived from a/victoria/2570/2019) 15 µg, haemagglutininum influenzae a (h3n2) (virus stamm a/cambodia/e0826360/2020 (h3n2)-like: reassortant virus ivr-221 derived from a/tasmania/503/2020) 15 µg, haemagglutininum influenzae b (virus stamm b/washington/02/2019-like: reassortant virus b/washington/02/2019 (victoria lineage)) 15 µg, haemagglutininum influenzae b (virus stamm b/phuket/3073/2013 (yamagata lineage)) 15 µg, polysorbatum 80, octoxinolum-10, natrii chloridum, magnesii chloridum hexahydricum, dinatrii phosphas dodecahydricus, kalii dihydrogenophosphas, kalii chloridum, alpha-tocopheroli hydrogenosuccinas, aqua ad iniectabile q.s. ad suspensionem pro 0.5 ml, residui: ovalbuminum, formaldehydum, natrii desoxycholas, gentamicini sulfas, hydrocortisonum. - aktive immunisierung gegen influenza, ab 36 monaten - impfstoffe

Uswisi - Kijerumani - Swissmedic (Swiss Agency for Therapeutic Products)

sanofi-aventis (suisse) sa - haemagglutininum influenzae a (h1n1) (virus souche a/victoria/2570/2019 (h1n1)-pdm09: reassortant virus ivr-215 derived from a/victoria/2570/2019), haemagglutininum influenzae a (h3n2) (virus souche a/cambodia/e0826360/2020 (h3n2)-like: reassortant virus ivr-221 derived from a/cambodia/e0826360/2020), haemagglutininum influenzae b (virus souche b/washington/02/2019 (victoria lineage)) - suspension zur injektion in einer fertigspritze - haemagglutininum influenzae a (h1n1) (virus souche a/victoria/2570/2019 (h1n1)-pdm09: reassortant virus ivr-215 derived from a/victoria/2570/2019) 15 µg, haemagglutininum influenzae a (h3n2) (virus souche a/cambodia/e0826360/2020 (h3n2)-like: reassortant virus ivr-221 derived from a/cambodia/e0826360/2020) 15 µg, haemagglutininum influenzae b (virus souche b/washington/02/2019 (victoria lineage)) 15 µg, haemagglutininum influenzae b (virus souche b/phuket/3073/2013 (yamagata lineage)) 15 µg, natrii chloridum, kalii chloridum, dinatrii phosphas dihydricus, kalii dihydrogenophosphas, aqua ad iniectabile q.s. ad suspensionem pro 0.5 ml corresp. natrium 1.72 mg, kalium 0.08 mg, residui: formaldehydum, octoxinolum-9, neomycinum, ovalbuminum. - aktive immunisierung gegen influenza, ab dem 6. monat - impfstoffe

Uswisi - Kijerumani - Swissmedic (Swiss Agency for Therapeutic Products)

mylan pharma gmbh - haemagglutininum influenzae a (h1n1) (virus-stamm a/victoria/2570/2019 (h1n1)-pdm09: reassortant virus ivr-215 derived from a/victoria/2570/2019), haemagglutininum influenzae a (h3n2) (virus-stamm a/cambodia/e0826360/2020 (h3n2)-like: reassortant virus ivr-224 derived from a/cambodia/e0826360/2020), haemagglutininum influenzae b (virus-stamm b/washington/02/2019 (victoria lineage)) - injektionssuspension - haemagglutininum influenzae a (h1n1) (virus-stamm a/victoria/2570/2019 (h1n1)-pdm09: reassortant virus ivr-215 derived from a/victoria/2570/2019) 15 µg, haemagglutininum influenzae a (h3n2) (virus-stamm a/cambodia/e0826360/2020 (h3n2)-like: reassortant virus ivr-224 derived from a/cambodia/e0826360/2020) 15 µg, haemagglutininum influenzae b (virus-stamm b/washington/02/2019 (victoria lineage)) 15 µg, haemagglutininum influenzae b (virus-stamm b/phuket/3073/2013 (yamagata lineage)) 15 µg, kalii chloridum, kalii dihydrogenophosphas, dinatrii phosphas dihydricus, natrii chloridum, calcii chloridum dihydricum, magnesii chloridum hexahydricum, aqua ad iniectabile q.s. ad suspensionem pro 0.5 ml corresp. natrium 2.0 mg, kalium 0.1 mg, residui: cetrimidum, formaldehydum, gentamicini sulfas, polysorbatum 80, ovalbuminum. - aktive immunisierung gegen influenza, ab 6 monaten - impfstoffe

Uswisi - Kijerumani - Swissmedic (Swiss Agency for Therapeutic Products)

omida ag - arnica montana d6, washington e früchte, frisch d2, kalmia latifolia d4, lycopus virginicus d3, scutellaria lateriflora d3 - homöopathische herztropfen - arnica montana d6, washington e früchte, frisch d2, kalmia latifolia d4, lycopus virginicus d3, scutellaria lateriflora d3 ana teile der lösung zu endwerte. ethanolum 30 % v/v. - bei nervösen herzbeschwerden - homöopathische arzneimittel

Uswisi - Kijerumani - Swissmedic (Swiss Agency for Therapeutic Products)

ebi-pharm ag - amanita muscaria (hab) d6, carbon-gemüse (hab) d8, washington spag. peka tm, cytisus scoparius spag. peka d3, nicotiana tobago d6, veratrum album (hab) d4 - tropfen zum einnehmen - amanita muscaria (hab) d6 150 mg, carbon-gemüse (hab) d8 150 mg, washington spag. peka tm 250 mg, cytisus scoparius spag. peka d3 150 mg, nicotiana tobago d6 150 mg, veratrum album (hab) d4 150 mg-lösung pro 1 g, endwerte. ethanolum 22 % v/v. - gemäss homöopathischem arzneimittelbild bei beschwerden bei niederem blutdruck - homöopathische arzneimittel

Uswisi - Kijerumani - Swissmedic (Swiss Agency for Therapeutic Products)

omida ag - digitalis purpurea, d4, 20.0 %; washington, d1, 20.0 %; adonis vernalis d4, 20.0 %; convallaria majalis d4, 20.0 %; apocynum cannabinum d4, 20.0 % - tropfen / spray, globuli, tabletten - d - digitalis purpurea, d4, 20.0 %; adonis vernalis d4, 20.0 %; washington, d1, 20.0 %; convallaria majalis d4, 20.0 %; apocynum cannabinum d4, 20.0 % - homöopathisch

Uswisi - Kijerumani - Swissmedic (Swiss Agency for Therapeutic Products)

ebi-pharm ag - cytisus scoparius, d6, 0.12 mg / 1 gramm; und war aparine, tm 0,06 mg / 1 gramm; calcium fluoratum, d8, 0.12 mg / 1 gramm; efeu helix, d3, 0.14 mg / 1 gramm; lophophytum leandri, d4, 0,15 mg / 1 gramm; washington, tm 0,1 mg / 1 gramm; magnesium carbonicum, d8, 0.14 mg / 1 gramm; conium unreine, d6, 0.17 mg / 1 gramm - tropfen / spray - d - cytisus scoparius, d6, 0.12 mg / 1 gramm; und war aparine, tm 0,06 mg / 1 gramm; calcium fluoratum, d8, 0.12 mg / 1 gramm; efeu helix, d3, 0.14 mg / 1 gramm; lophophytum leandri, d4, 0,15 mg / 1 gramm; magnesium carbonicum, d8, 0.14 mg / 1 gramm; washington, tm 0,1 mg / 1 gramm; conium unreine, d6, 0.17 mg / 1 gramm - homöopathisch-spagyrisch

Uswisi - Kijerumani - Swissmedic (Swiss Agency for Therapeutic Products)

boiron sa - cinchona succirubra, c3, 14.28 %; chelidonium größer, c3, 14.28 %; washington, c3, 14.28 %; scrophularia nodosa, c3, 14.28 %; hydrastis kanadischen, c3, 14.28 %; marsdenia cundurango, c3, 14.28 %; ceanothus (b, c3, 14.28 % - tropfen / spray, globuli, tabletten - d - cinchona succirubra, c3, 14.28 %; chelidonium größer, c3, 14.28 %; washington, c3, 14.28 %; scrophularia nodosa, c3, 14.28 %; hydrastis kanadischen, c3, 14.28 %; marsdenia cundurango, c3, 14.28 %; ceanothus (b, c3, 14.28 % - homöopathisch

Uswisi - Kijerumani - Swissmedic (Swiss Agency for Therapeutic Products)

hans rentsch ag - viscum album d4, 200.0 mg / 1 gramm; Öle europäischen union, tm, 200.0 mg / 1 gramm; rauwolfia schlange -, d4, 200.0 mg / 1 gramm; washington, tm, 200.0 mg / 1 gramm; solidago virgaurea, tm, 200.0 mg / 1 gramm - tropfen / spray - d - Öle die europäische union, tm, 200.0 mg / 1 gramm; viscum album d4, 200.0 mg / 1 gramm; rauwolfia schlange -, d4, 200.0 mg / 1 gramm; washington, tm, 200.0 mg / 1 gramm; solidago virgaurea, tm, 200.0 mg / 1 gramm - homöopathisch

Uswisi - Kijerumani - Swissmedic (Swiss Agency for Therapeutic Products)

herbamed ag - selenicereus grandiflorus, tm, 20.0 %; rosmarin officinalis, tm, 20.0 %; hyssopus officinalis, tm, 20.0 %; washington, tm, 40.0 % - tropfen / spray, globuli - b - rosmarin officinalis, tm, 20.0 %; selenicereus grandiflorus, tm, 20.0 %; hyssopus officinalis, tm, 20.0 %; washington, tm, 40.0 % - homöopathisch